Viral hepatitis: Cost-effectiveness of direct-acting antivirals for chronic hepatitis C. (Q42995272)

12 November 2017

title

Viral hepatitis: Cost-effectiveness of direct-acting antivirals for chronic hepatitis C. (English)

1 reference

12 November 2017

1 reference

Gaby Sroczynski

1 reference

12 November 2017

Uwe Siebert

series ordinal

1 reference

12 November 2017

language of work or name

English

0 references

publication date

20 August 2013

1 reference

Nature Reviews Gastroenterology & Hepatology

12 November 2017

published in

1 reference

12 November 2017

1 reference

12 November 2017

1 reference

12 November 2017

page(s)

572-574

1 reference

Long-term effectiveness and cost-effectiveness of antiviral treatment in hepatitis C.

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.162

Effectiveness and cost-effectiveness of initial combination therapy with interferon/peginterferon plus ribavirin in patients with chronic hepatitis C in Germany: a health technology assessment commissioned by the German Federal Ministry of Health an

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.162

New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.162

Economic evaluation of direct-acting antiviral therapy in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.162

Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.162

Review of direct-acting antiviral agents for the treatment of chronic hepatitis C.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.162

State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.162

Key principles for the improved conduct of health technology assessments for resource allocation decisions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.162

10.1038/NRGASTRO.2013.162

31 March 2020

Identifiers

DOI

1 reference

Dimensions Publication ID

12 November 2017

1004708250

0 references

1 reference